Max Healthcare Institute Limited Stock

Equities

MAXHEALTH

INE027H01010

Healthcare Facilities & Services

Market Closed - Bombay S.E. 06:00:47 2024-04-24 am EDT 5-day change 1st Jan Change
813 INR +6.92% Intraday chart for Max Healthcare Institute Limited -0.62% +18.23%
Sales 2024 * 68.52B 823M Sales 2025 * 83.52B 1B Capitalization 790B 9.49B
Net income 2024 * 13.22B 159M Net income 2025 * 15.96B 192M EV / Sales 2024 * 11.3 x
Net cash position 2024 * 13.6B 163M Net cash position 2025 * 13.58B 163M EV / Sales 2025 * 9.3 x
P/E ratio 2024 *
60.2 x
P/E ratio 2025 *
50.5 x
Employees 15,000
Yield 2024 *
0.16%
Yield 2025 *
0.18%
Free-Float 76.25%
More Fundamentals * Assessed data
Dynamic Chart
Max Healthcare Institute Acquires Additional 3% Stake in Sandhya Hydro Power MT
AppLovin Corporation : The future of app marketplace? Our Logo
Max Healthcare Institute Plans INR50 Billion Investment to Double Capacity MT
Max Healthcare Acquires Land in Lucknow, India to Build New Hospital MT
Max Healthcare Institute Limited Announces Update on Acquisition of Land Parcel Allotted Through E-Auction for Setting Up of 500+ Bedded Hospital in Lucknow CI
Max Healthcare Institute Acquires Land in Lucknow, India, to Develop New Hospital MT
Max Healthcare Institute Limited Approves Expansion of Company's Footprint in Lucknow, Uttar Pradesh CI
Max Healthcare Completes Acquisition of Alexis Multi-Specialty Hospital MT
Indian Equities Close the Week Higher, Aided by Rebound in Banking Stocks MT
Max Healthcare Institute Buys Alexis Multi-Speciality Hospital for INR4.1 Billion MT
Max Healthcare Institute Limited agreed to acquire Alexis Multi-speciality Hospital Private Limited for approximately INR 3720 million. CI
Jefferies Adjusts Max Healthcare Institute’s Price Target to INR915 From INR800, Keeps at Buy MT
Max Healthcare Institute Posts Gains in Fiscal Q3 Consolidated Net Profit MT
Transcript : Max Healthcare Institute Limited, Q3 2024 Earnings Call, Feb 01, 2024
Max Healthcare Institute Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
More news

Latest transcript on Max Healthcare Institute Limited

1 day+6.92%
1 week-0.62%
Current month-0.91%
1 month+9.93%
3 months+4.74%
6 months+40.82%
Current year+18.23%
More quotes
1 week
748.45
Extreme 748.45
824.35
1 month
737.95
Extreme 737.95
894.95
Current year
669.65
Extreme 669.65
909.00
1 year
435.10
Extreme 435.1
909.00
3 years
205.00
Extreme 205
909.00
5 years
64.95
Extreme 64.95
909.00
10 years
64.95
Extreme 64.95
909.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 19-06-20
Director of Finance/CFO 60 12-01-14
Chief Operating Officer - 19-06-30
Members of the board TitleAgeSince
Director/Board Member 66 09-08-25
Director/Board Member 67 23-05-15
Director/Board Member 61 19-06-20
More insiders
Date Price Change Volume
24-04-24 813 +6.92% 63,737
24-04-23 760.4 +0.23% 47,834
24-04-22 758.6 -1.73% 30,357
24-04-19 772 -0.53% 28,072
24-04-18 776.1 -5.12% 132,448

Delayed Quote Bombay S.E., April 24, 2024 at 06:00 am EDT

More quotes
Max Healthcare Institute Limited is an India-based integrated healthcare provider. The Company operates through a single segment, which is Medical and Healthcare Services. It provides a wide array of services ranging from primary to quaternary care, including advanced cardiac care, orthopedics, oncology, neurosciences, transplants, minimal access metabolic and bariatric surgery, and other services, including obstetrics and gynecology, pediatrics and nephrology. The Company also provides outpatient services, including consultations for a range of ailments, preventive health screenings, and laboratory services as well as radiology, imaging and emergency services. The Company has two strategic business units (SBUs): Max Lab and Max@Home. The Company owns and operates approximately 17 healthcare facilities across the Delhi national capital region (NCR), Haryana, Punjab, Uttarakhand and Maharashtra. Max Lab offers diagnostic services to patients outside its network.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
813 INR
Average target price
844.2 INR
Spread / Average Target
+3.85%
Consensus
  1. Stock Market
  2. Equities
  3. MAXHEALTH Stock